These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 28196642)
1. So long, Farewell, Au revoir, Auf Weidersehen. In regard to Overgaard (Radiother Oncol. 2016 Dec; 121(3):345-347). Salem A Radiother Oncol; 2017 Mar; 122(3):486. PubMed ID: 28196642 [No Abstract] [Full Text] [Related]
2. So long, Farewell, Au revoir, Auf Weidersehen. Overgaard J Radiother Oncol; 2016 Dec; 121(3):345-347. PubMed ID: 28007377 [No Abstract] [Full Text] [Related]
3. Au revoir, from Derek Doyle: farewell address held in Geneva. Support Care Cancer; 2000 Mar; 8(2):77-9. PubMed ID: 10739351 [No Abstract] [Full Text] [Related]
4. Au revoir, Auf Wiederzhen..... Thomson A Midwifery; 2005 Dec; 21(4):299-300. PubMed ID: 16311137 [No Abstract] [Full Text] [Related]
5. Goodbye, adiós, farväl, au revoir, adjö, arrivederci, vaarwel, do widzenia, auf wiedersehen…. Jaarsma T; Thompson DR; Stromberg A Eur J Cardiovasc Nurs; 2022 Jan; 21(1):1. PubMed ID: 34788434 [No Abstract] [Full Text] [Related]
6. An international review of patient safety measures in radiotherapy practice: Shafiq J, Barton M, Noble D, Lemer C, Donaldson LJ. Radiother Oncol. 2009 Jul;92(1):15-21. Clark BG; Grimard L Radiother Oncol; 2009 Dec; 93(3):657. PubMed ID: 19767116 [No Abstract] [Full Text] [Related]
7. Corrigendum to "Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy" [Radiother Oncol 150 (2020) 114-120]. Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Angelica Cortez M; Welsh JW Radiother Oncol; 2021 May; 158():332-334. PubMed ID: 33714536 [No Abstract] [Full Text] [Related]
8. Farewell to Prof. Jens Overgaard. Baumann M Radiother Oncol; 2017 Jan; 122(1):1. PubMed ID: 28094074 [No Abstract] [Full Text] [Related]
9. Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117]. Price JM; West CM; Dixon LM; Iyizoba-Ebozue Z; Garcez K; Lee LW; McPartlin A; Williams G; Slevin F; Sykes A; Prestwich RJD; Thomson DJ Radiother Oncol; 2022 Dec; 177():163. PubMed ID: 36395551 [No Abstract] [Full Text] [Related]
10. Re: new radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Sterotactic radiotherapy? Intensity modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy? Or nothing at all? [Radiother Oncol 2004;71(3):247-249]. Bauman GS; Wong E Radiother Oncol; 2004 Nov; 73(2):251-2. PubMed ID: 15542173 [No Abstract] [Full Text] [Related]
11. Letter to the editor concerning Senan et al., [Radiother Oncol 2004;71:139-146]. Weiss E; Vorwerk H; Keall PJ; Pradier O; Christiansen H; Hille A; Hess CF Radiother Oncol; 2005 Mar; 74(3):346-7. PubMed ID: 15763318 [No Abstract] [Full Text] [Related]
12. Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]. Putora PM; Glatzer M; De Ruysscher D; Faivre-Finn C; Belderbos J; Besse B; Blackhall F; Califano R; Cappuzzo F; de Marinis F; Dziadiuszko R; Felip E; Früh M; Garrido P; Le Pechoux C; McDonald F; Nestle U; Novello S; O' Brien M; Paz Ares L; Peeters S; Pöttgen C; Ramella S; Reck M; Troost EGC; Van Houtte P; Westeel V; Widder J; Mornex F; Slotman BJ Radiother Oncol; 2019 Dec; 141():332. PubMed ID: 31810511 [No Abstract] [Full Text] [Related]
13. Corrigendum to "Master protocol trial design for technical feasibility of MR-guided radiotherapy" [Radiother. Oncol. 166 (2022) 33-36]. Couwenberg A; Van der Heide U; Janssen T; Van Triest B; Remeijer P; Marijnen C; Sonke JJ; Nowee M Radiother Oncol; 2023 Jul; 184():109693. PubMed ID: 37207559 [No Abstract] [Full Text] [Related]
14. Corrigendum to "Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas" [Radiother. Oncol. 158 (2021) 33-39]. Lansu J; van Houdt WJ; van Langevelde K; van den Ende PLA; van der Graaf WTA; Schrage Y; van Boven H; Scholten AN; Haas RL Radiother Oncol; 2021 Oct; 163():245. PubMed ID: 34243980 [No Abstract] [Full Text] [Related]
15. Comment on: 'Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients' Radiother Oncol 70: 261-264, 2004 by Dr Rades et al. Cengiz M; Onal C; Yildiz F; Zorlu AF Radiother Oncol; 2004 Oct; 73(1):109; author reply 109-10. PubMed ID: 15465155 [No Abstract] [Full Text] [Related]